Antares Vision S p A : 01 March - Procedures and Exercise Ratio of Antares Vision Warrants

PRESS RELEASE

PROCEDURES AND EXERCISE RATIO OF ANTARES VISION WARRANTS

Travagliato (Brescia), 1 March 2024 - Antares Vision S.p.A. ("Antares Vision" or the "Company") announces that, pursuant to article 3 of the Regulation of "Antares Vision S.p.A. Warrants" (respectively, the "Warrants Regulation"1 and the "Warrants"), the Average Monthly Price for February 2024 is Euro 2.1379 (source FactSet, Average Monthly Price calculated as the arithmetic average of the official prices of ordinary Antares Vision S.p.A. shares on stock market trading days in February).

Therefore, since the Average Monthly Price for February 2024, equal to Euro 2.1379, is lower than the Strike Price, equal to 9.50 euros, the warrants cannot be exercised during the month of March 2024.

Antares Vision also announces that, in January, the warrants could not be exercised. Consequently, the share capital of Antares Vision (Euro 169,456.78, divided into 69,121,137 ordinary shares, 250,000 Special Shares and 1,189,590 Performance Shares, with no nominal value indicated for any category) remained unchanged as well as the warrants outstanding (equal to 2,460,400).

For any further information, please refer to the Warrants Regulation available on the website of Antares Vision www.antaresvisiongroup.com- "Investors - Investor Relations - Warrant" section.

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness, and environmental protection. The Group provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. Antares Vision Group is active in life science (pharmaceutical, biomedical devices and hospitals) and Fast-Moving Consumer Goods (FMCG), including food, beverage, cosmetics, and glass and metal containers. As a world leader in track and trace solutions for pharmaceutical products, the Group provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of Euronext; furthermore, from July 2022 included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential. In 2021, Antares Vision Group recorded a turnover of €179m, operates in 60 countries, employs more than 1,000 people, and has a consolidated network of over 40 international partners. To learn more, please visitwww.antaresvisiongroup.com.

1 The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Regulation.

PRESS RELEASE

For further information

ISSUER

ANTARES VISION GROUP

ALESSANDRO BAJ BADINO (HEAD OF INVESTOR RELATIONS)

TEL.: [phone]

E-MAIL:[e-mail]

DAVIDE ANTONIOLI (INVESTOR RELATOR)

TEL.: [phone]

E-MAIL:[e-mail]